Iridium Awarded 5-Year System Infrastructure Transformation and Hybridization Contract Worth Up to $85.8 Million
New Contract Supports Enhancements to the Iridium and U.S. DoD EMSS Service Center and Related Facilities MCLEAN, Va., Dec. 2, 2025 /PRNewswire/ — Iridium... Read more.
Halcyon Named to Inc.’s 2025 Best in Business List in Best Startups category
The company was recognized for the launch of two industry-first programs designed to defeat ransomware threats AUSTIN, Texas, Dec. 2, 2025 /PRNewswire/ — Halcyon,... Read more.
Nexar Named to Inc.’s 2025 Best in Business List for General Excellence
The annual list recognizes the industry-leading companies that are the best at what they do NEW YORK, Dec. 2, 2025 /PRNewswire/ — Nexar, a leader in AI-powered... Read more.
Recurrent Energy Secures Development Consent Order for the Tillbridge Solar and Battery Storage Project in the UK
The project combines 800 MW of solar PV and 500 MW / 1,000 MWh of battery energy storage, marking a major milestone in Recurrent Energy’s UK growth strategy.... Read more.
Quest Analytics Receives Renewed CMS Contract to Measure Network Adequacy for Medicare Advantage, Pharmacy Plans
OVERLAND PARK, Kan., Dec. 2, 2025 /PRNewswire/ — Quest Analytics, the leader in provider network design and management solutions, announced today that the... Read more.
Origin Agritech’s Pioneering Hi3 Gene Editing Technology Awarded as Top 10 Major Progress in Chinese Agricultural Science for 2025, as Company Advances Commercialization
BEIJING, Dec. 2, 2025 /PRNewswire/ — Origin Agritech Ltd. (NASDAQ: SEED) (the “Company” or “Origin”), a leading Chinese agricultural... Read more.
Westbridge Renewable Receives final transmission and connection approvals from the Alberta Utilities Commission for Dolcy Solar + Energy Storage Project
CALGARY, AB, Dec. 2, 2025 /PRNewswire/ – Westbridge Renewable Energy Corporation (TSXV: WEB, OTCQX: WEGYF, FRA: PUQ) (“Westbridge”, “Westbridge... Read more.
Nanoscope Therapeutics’ MCO-010 Optogenetic Therapy Featured at FLORetina-ICOOR 2025 Congress
DALLAS, Dec. 2, 2025 /PRNewswire/ — Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic... Read more.
Xona and spotit Partner to Deliver Secure Access for Critical Infrastructure Across Europe
Strategic MSSP partnership enables frictionless, policy-enforced access to OT, ICS, and CPS environments, without compromising cybersecurity or compliance... Read more.
AISA Pharma Announces Completion of Enrollment in Phase 2 RECONNOITER Trial of AISA-021 in Systemic Sclerosis-Related Raynaud’s Phenomenon
Results from Phase 2 RECONNOITER trial accepted as oral presentation at World Systemic Sclerosis Conference in Athens, Greece March 5-7, 2026 Dr. Norman Stockbridge,... Read more.